NPL and renal carcinoma: In particular, RASAL1 overexpression resulted significantly correlated with a worse outcome (increased death) in endometrial cancer (Figure S1D), whereas NPL overexpression was correlated to a worse outcome in liver and renal cancers (Figure S1E).